Sutro Biopharma, Inc. (STRO)

Sutro Biopharma Revenue

Sutro Biopharma had revenue of $63.75M in the quarter ending June 30, 2025, with 147.98% growth. This brings the company's revenue in the last twelve months to $104.47M, down -38.31% year-over-year. In the year 2024, Sutro Biopharma had annual revenue of $62.04M, down -59.64%.

• Revenue (ttm): $104.47M
• Revenue Growth: -38.31%
• P/S Ratio: 0.71
• Revenue / Employee: $337,010
• Employees: 310
• Market Cap: 75.16M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	62.04M	-91.69M	-59.64%
Dec 31, 2023	153.73M	85.96M	126.84%
Dec 31, 2022	67.77M	5.89M	9.52%
Dec 31, 2021	61.88M	19.16M	44.84%
Dec 31, 2020	42.72M	-14.00K	-0.03%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.